Abstract. Osterix was identified as a transcription factor expressing, in osteoblasts, required for bone formation. However, the molecular mechanisms of the gene regulation by Osterix remain elusive. In this study, we examined the transactivation property of Osterix by using the Gal4 fusion system reporter assay. We identified the transactivation domain of Osterix, which contains high proline and glycine residues and has an activation property in mammalian and yeast cells. The GST-pull down analysis revealed that the basal transcription factor, TF-IIB, but not TBP, binds to the transactivation domain. Furthermore, we found that Osterix interacts with chromatin remodeling factor, Brg-1, through its C-terminal zinc finger domain in vivo and in vitro. These findings suggest that Osterix possesses functional domains which associate with transcription mediated factors and functions as a transcriptional activator in the nucleus.
Introduction
Osteoblasts are cells of mesodermal origin that play a pivotal role in bone formation. The expression of osteoblast-specific genes, such as alkaline phosphatase, osteocalcin, and type 1 collagen, is activated during osteoblast differentiation. In the nucleus, many transcription factors and transcriptional cofactors dynamically interact with each other and regulate their target gene expression in this period (1) (2) (3) (4) . The runt family transcription factor, Runx2/Cbfa1, has previously been shown to be required for osteoblast differentiation (5-7). Furthermore, Nakashima et al (8) reported that the zinc finger transcription factor, Osterix, plays an essential role during osteoblast differentiation, and contributes to gene expression at a later step than Runx2/Cbfa1.
Osterix contains the unique N-terminal and middle regions, and three zinc finger domains in the C-terminal region. The C-terminal zinc finger region of Osterix shows high homology to the Sp-1/Kruppel-like transcription factors. It is assumed that the N-terminal and middle regions possess a transcriptional regulatory property, and that the three-zincfinger domain recognizes the Sp-1-like G/C-rich sequence (9) (10) (11) (12) . Although the study on an Osterix null mouse revealed that Osterix is essential for osteoblast differentiation, the molecular mechanisms controlling osteoblast-specific gene expression by Osterix are still unknown.
In the present study, we first identified the transactivation domain of Osterix by means of the Gal4 fusion system in mammalian cell lines and yeast cells, and showed that the transactivation domain associates with TF-IIB, but not TBP. Furthermore we revealed that the C-terminal zinc finger domain of Osterix binds to chromatin remodeling factor Brg-1. These results indicated that Osterix functions through its multiple domains associating with gene expressionmediated factors in the nucleus.
Materials and methods
Plasmid construction. Mouse Osterix cDNA was cloned from total cellular RNA of MC3T3-E1 cells by reverse transcription PCR with the oligonucleotide primers, 5'-CGCGGATCCAT GGCGTCCTCTCTGCTTGAGGAA-3' for the 5' side and 5'-CGCGGATCCTCAGATCTCTAGCAGGTTGCTCTG-3' for the 3' side. pcDNA3-FLAG-Osterix was constructed by subcloning full-length Osterix cDNA in-flame into the BamHI site in pcDNA3-FLAG. GST fusion constructs of full-length Osterix and various deletion mutants were obtained by ligating the appropriate coding sequence downstream and in-frame into pGEX-6P-2 (Amersham Bioscience). pGAL4 control vector was generated by inserting the GAL4 DNA-binding domain [GAL4DBD (amino acid 1-147)] into the HindIII site in pcDNA3 (13) . GAL4 fusion constructs of full-length Osterix and various deletion mutants were obtained by ligating the appropriate coding sequence downstream and in-frame into GAL4DBD in pGAL4. pG5b-Luc luciferase reporter plasmid was made by inserting 5 copies of GAL4 binding sequence and TATA sequence in adenovirus E1B promoter upstream into the luciferase coding sequence (13 Osterix expression plasmids, and pRL-CMV at 60% confluence. pRL-CMV control plasmid was included in each transfection experiment to control for the efficiency of transfection. After transfection, the cells were cultured in DMEM or MEM supplemented with 10% fetal bovine serum for 48 h, and then harvested using 100 μl of passive lysis buffer. Luciferase assay was performed using the dual luciferase reporter assay system (Promega), and samples were loaded on Luminescencer-PSN (ATTO) to measure the luciferase activity. Saccharomyces cerevisiae strain Y190 was transformed with Osterix deletion mutant expression plasmids by lithium acetate method, and transformants were selected by incubation on agar plates lacking tryptophan for 3 days. The liquid ß-galactosidase assay was conducted by standard method.
Briefly, 1 ml of growth medium was inoculated with selected colonies. The cells were harvested and incubated with ß-galactosidase assay buffer containing ortho-nitro-phenolgalactosidase at 30˚C. The activity was measured by an optical density of 420 nm divided by time of incubation and number of cells.
Antibodies. Mouse monoclonal antibody against the Flag tag (M2) was purchased from Sigma. Rabbit polyclonal antibody against Brg-1 (H-88), rabbit polyclonal antibody against TF-IIB (C-18), and mouse monoclonal antibody against TBP Immunoprecipitation and immunoblotting analysis. HEK293T cells were transfected with pcDNA3 or pcDNA3-FLAGOsterix, and lysed in lysis buffer A [10 mM HEPES-KOH (pH 7.6), 150 mM KCl, 0.1% NP-40, 1 mM PMSF]. The cell lysates were incubated with anti-FLAG antibody (M2) and protein G sepharose for 2 h at 4˚C. After washing with lysis buffer A, the immunocomplexes were resolved by SDSpolyacrylamide gel electrophoresis, followed by electrotransfer onto PVDF membrane (Millipore). After transfer, the membrane was incubated with TBS-T (TBS with 0.1% Tween-20) with 5% skim milk for 1 h at room temperature, followed by anti-FLAG antibody (M2) or anti-Brg-1 antibody, overnight at 4˚C. The membrane was washed with TBS-T and incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies for 1 h at room temperature. Finally, the membrane was washed with TBS-T and detection was conducted using ECL plus (Amersham Biosciences).
GST-pull down analysis. The GST fusion proteins of osterix and osterix deletion mutants were expressed in Escherichia coli strain, BL21, and purified using glutathione-sepharose beads (Amersham Biosciences). The cell extract obtained from HEK293T cells was incubated with 2 μg of each GST fusion protein bound to resin for 4 h at 4˚C. After washing with lysis buffer A, bound proteins were fractionated by SDS-polyacrylamide gel electrophoresis and analyzed by immunoblotting.
Results
To assess the transactivation activity of Osterix, we utilized the Gal4 fusion system in human osteosarcoma MG63 cells. We constructed the expression plasmids containing full-length Osterix and various deletion fragments in frame to the Gal4 DNA-binding domain (Fig. 1A) . As shown in Fig. 1B , the constructs containing the middle region of Osterix (residues 141-280) showed transactivation activity, whereas the Nterminal (residues 1-141) and C-terminal (residues 280-429) regions had no activity. Further analysis using deletion mutants of the middle region revealed that the OST-B1 region (residues 141-210) had strong transactivation activity (Fig. 1C) .
To determine whether the OST-B1 region is essential for the transactivation property of Osterix, we constructed the Gal4 fusion ΔTAD Osterix in which the OST-B1 region is deleted ( Fig. 2A) , and conducted the reporter assay. ΔTAD displayed a significant decrease in the transactivation activity compared with wild-type Osterix and OST-B1 region (Fig. 2B) .
Osterix is an osteoblast-specific transcription factor, and essential for bone formation (8) . Therefore, we tested whether Osterix can act as a transcriptional activator in various cell lines, which are derived from different tissue. Four cell lines (MG63, HeLa, HepG2, and HEK293T cells) were transfected with G5b-Luc and the Gal4 fusion Osterix, or OST-B1 expression plasmid. Both Osterix (Fig. 3A) and the OST-B1 region (Fig. 3B) provided transcriptional activation in a cell type-independent manner. These results suggest that the OST-B1 region is essential for the transactivation property of Osterix and can act as a transactivation domain in various cell types.
The OST-B1 region contains a unique proline-glycine-rich sequence, which shares no significant similarity with other Sp-1/Kruppel-like transcription factors (Fig. 4A) . A previous study reported that the proline-rich activation domain of NF-1/ CTF1 associates with TF-IIB, but not TATA binding protein (TBP), and functions in both mammalian and yeast systems (13) . Thus, we examined whether the transactivation domain of Osterix possesses these activities. First, we performed GST-pull down assay, and revealed that the OST-B1 region interacts with TF-IIB, but not TBP. Furthermore, we conducted ß-galactosidase assay by using Y190 yeast cells. As shown in Tissue-specific transcription factors regulate tissuerestricted gene expression though interaction with transcriptional coactivators, chromatin remodeling complexes, and basal transcriptional machinery (14) . EKLF, an erythroid- specific Kruppel-like transcription factor, plays an essential role in ß-globin gene expression (15) . EKLF modulates the chromatin structure of the ß-globin gene through the binding activity of the C-terminal zinc finger domain to Brg-1 containing SWI/SNF chromatin remodeling complexes (16) . To assess whether Osterix interacts with Brg-1, we first conducted immunoprecipitation analysis, and revealed that Osterix associates with Brg-1 in vivo. To further investigate the binding domain of Osterix to Brg-1 (Fig. 5A ), we performed GST-pull down assay by using various Osterix deletion proteins. As shown in Fig. 5B , Brg-1 associated with the C-terminal region of Osterix. These results indicate that the C-terminal domain containing three C2H2 zinc fingers of Osterix, like EKLF, possesses binding activity to Brg-1.
Discussion
In this study, we found the functional domains of Osterix possessing binding activity to gene expression-mediated factors (Fig. 6) . First, we analyzed the transactivation property of Osterix, and identified the transcriptional activation domain (residues 141-210) containing a proline-glycine rich sequence. The transactivation domains were studied by classifying into the acidic activation domain, the glutamine-rich activation domain, and the proline-rich activation domain. The acidic activation domain was present in yeast transcription factor, GAL4, and herpes simplex virus, VP16. The glutamine-rich activation domain was found in Sp-1, and the proline-rich activation domain was found in NF-1/CTF1. We revealed that the transactivation domain of Osterix, like the prolinerich activator domain of NF-1/CTF1, interacts with TF-IIB, but not TBP, and functions in both mammalian and yeast cells.
Osterix contains three C2H2 zinc fingers in the C-terminal domain that share a high degree of identity with motifs of Sp-1 and Sp-3. However, the N-terminal and middle regions share no significant similarity with any other transcription factors (8) . Furthermore, the transactivation domain of Osterix contains a proline-glycine-rich sequence. On the other hand, Sp-1 and Sp-3 possess the glutamine-rich activation domain. The difference in activation domains may lead to the difference in their roles in gene regulation, since no other C2H2 zinc finger containing transcription factors, such as Sp-1 and Sp-3, can substitute for the function of Osterix in osteoblast differentiation. The promoter region in the alkaline phosphatase gene contains the Sp-1-like G/C-rich sequence. Several studies reported that Sp family transcription factors regulate alkaline phosphatase promoter activity (17, 18 ). Thus, we tested whether Osterix potentiates alkaline phosphatase promoter activity. Interestingly, the reporter assay revealed that there is no involvement of Osterix in the regulation of alkaline phosphatase promoter activity (data not shown).
Furthermore, we identified that Osterix interacts with Brg-1. Brg-1 is a catalytic component of SWI/SNF chromatin remodeling complexes. SWI/SNF complexes have been implicated in remodeling local chromatin structure, permitting increased access of transcriptional activators to their recognition sites in the target genes (19) . Several studies reported that the transcription factors, such as EKLF, C/EBP, and MyoD, which play an essential role in tissue-differentiation associate with SWI/SNF complexes and regulate the expression of tissue-specific genes (15, 20, 21) . The C-terminal zinc finger of Osterix shares high similarity with EKLF. Thus, it is possible that Osterix targets SWI/SNF complexes to osteoblast specific genes, and regulates osteoblast differentiation. However, less is known about the genes regulated by Osterix in osteoblast. Further study will be needed to assess the functional relevance between osteoblast-specific gene expression and the OsterixBrg-1 interaction. 
